Edition:
United States

Clementia Pharmaceuticals Inc (CMTA.OQ)

CMTA.OQ on NASDAQ Stock Exchange Global Select Market

13.51USD
18 Jan 2019
Change (% chg)

-- (--)
Prev Close
$13.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
18,212
52-wk High
$19.58
52-wk Low
$8.23

Chart for

About

Clementia Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need. Its lead product candidate, palovarotene, is an oral small molecule that binds and... (more)

Overall

Beta: --
Market Cap(Mil.): $474.83
Shares Outstanding(Mil.): 29.68
Dividend: --
Yield (%): --

Financials

  CMTA.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -- -- --
ROI: -- 8.99 14.48
ROE: -- 10.14 15.99

Earnings vs. Estimates